000			01302 a2200325 4500
005			20250514064209.0
264		0	_c20030508
008			200305s 0 0 eng d
022			_a1468-201X
024	7		_a10.1136/heart.89.suppl_2.ii28 _2doi
040			_aNLM _beng _cNLM
100	1		_aFisher, M
245	0	0	_aDiabetes: can we stop the time bomb? _h[electronic resource]
260			_bHeart (British Cardiac Society) _cMay 2003
300			_aii28-30; discussion ii35-7 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnticholesteremic Agents _xtherapeutic use
650	0	4	_aDiabetes Mellitus, Type 2 _xprevention & control
650	0	4	_aDiabetic Angiopathies _xprevention & control
650	0	4	_aHumans
650	0	4	_aHyperglycemia _xprevention & control
650	0	4	_aHypertension _xprevention & control
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aMyocardial Infarction _xprevention & control
650	0	4	_aPlatelet Aggregation Inhibitors _xtherapeutic use
650	0	4	_aRisk Factors
650	0	4	_aStroke _xprevention & control
773	0		_tHeart (British Cardiac Society) _gvol. 89 Suppl 2 _gp. ii28-30; discussion ii35-7
856	4	0	_uhttps://doi.org/10.1136/heart.89.suppl_2.ii28 _zAvailable from publisher's website
999			_c12487200 _d12487200